These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 16514628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
    Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M.
    J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
    [Abstract] [Full Text] [Related]

  • 3. Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.
    Levenson AS, Svoboda KM, Pease KM, Kaiser SA, Chen B, Simons LA, Jovanovic BD, Dyck PA, Jordan VC.
    Cancer Res; 2002 Aug 01; 62(15):4419-26. PubMed ID: 12154049
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cell type-specific bidirectional regulation of the glucocorticoid-induced leucine zipper (GILZ) gene by estrogen.
    Tynan SH, Lundeen SG, Allan GF.
    J Steroid Biochem Mol Biol; 2004 Aug 01; 91(4-5):225-39. PubMed ID: 15336700
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Basic guide to the mechanisms of antiestrogen action.
    MacGregor JI, Jordan VC.
    Pharmacol Rev; 1998 Jun 01; 50(2):151-96. PubMed ID: 9647865
    [Abstract] [Full Text] [Related]

  • 8. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells.
    Hurd C, Khattree N, Dinda S, Alban P, Moudgil VK.
    Oncogene; 1997 Aug 18; 15(8):991-5. PubMed ID: 9285694
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells.
    Rulli A, Antognelli C, Prezzi E, Baldracchini F, Piva F, Giovannini E, Talesa V.
    Breast Cancer Res Treat; 2006 Mar 18; 96(2):187-96. PubMed ID: 16319983
    [Abstract] [Full Text] [Related]

  • 11. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
    Fotovati A, Fujii T, Yamaguchi M, Kage M, Shirouzu K, Oie S, Basaki Y, Ono M, Yamana H, Kuwano M.
    Clin Cancer Res; 2006 May 15; 12(10):3010-8. PubMed ID: 16707596
    [Abstract] [Full Text] [Related]

  • 12. Targeted salmon gene array (SalArray): a toxicogenomic tool for gene expression profiling of interactions between estrogen and aryl hydrocarbon receptor signalling pathways.
    Mortensen AS, Arukwe A.
    Chem Res Toxicol; 2007 Mar 15; 20(3):474-88. PubMed ID: 17291011
    [Abstract] [Full Text] [Related]

  • 13. Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen.
    Pole JC, Gold LI, Orton T, Huby R, Carmichael PL.
    Toxicology; 2005 Jan 05; 206(1):91-109. PubMed ID: 15590111
    [Abstract] [Full Text] [Related]

  • 14. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
    Pennanen PT, Sarvilinna NS, Ylikomi TJ.
    Anticancer Drugs; 2009 Jan 05; 20(1):51-8. PubMed ID: 19343000
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.
    Yu K, Ganesan K, Miller LD, Tan P.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3288-96. PubMed ID: 16740749
    [Abstract] [Full Text] [Related]

  • 17. Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes.
    Sismondi P, Biglia N, Ponzone R, Fuso L, Scafoglio C, Cicatiello L, Ravo M, Weisz A, Cimino D, Altobelli G, Friard O, De Bortoli M.
    Maturitas; 2007 May 20; 57(1):50-5. PubMed ID: 17395409
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K.
    J Steroid Biochem; 1983 Jul 20; 19(1A):59-68. PubMed ID: 6887873
    [Abstract] [Full Text] [Related]

  • 20. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.
    J Steroid Biochem Mol Biol; 2000 Nov 30; 74(5):279-85. PubMed ID: 11162936
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.